KLK3 (Kallikrein-3), human recombinant protein
APS, KLK2A1, PSA, Hk3
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P07288 |
---|---|
Calculated MW | 35 kDa |
Gene ID | 354 |
---|---|
Gene Symbol | KLK3 |
Other Names | APS, KLK2A1, PSA, Hk3, P-30 antigen, Semenogelase |
Gene Source | Human |
Source | Human |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | N/A; |
Recombinant | Yes |
Results | >100 pmoles/min/ µg |
Application Notes | Detailed reconstitution instructions are sent along with the product. |
Format | Lyophilized protein |
Storage | -70°C; Lyophilized from sterile PBS, pH 7.4. (Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.) |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Prostate-specific antigen, also known as Gamma-seminoprotein, Kallikrein-3, kallikrein-related peptidase 3, Semenogelase, KLK3 and PSA, is a secreted protein which belongs to thepeptidase S1 family and Kallikrein subfamily. KLK3/Kallikrein 3 contains one peptidase S1 domain. KLK3/Kallikrein 3 is a glycoprotein produced almost exclusively by the prostate gland. KLK3/Kallikrein 3 is produced for the ejaculate where it liquifies the semen in the seminal coagulum and allows sperm to swim freely.It is also believed to be instrumental in dissolving the cervical mucous, allowing the entry of sperm. Human KLK3/Kallikrein 3 and human KLK2 are closely related products of the human kallikrein genes KLK3 and KLK2, respectively. Both KLK3/Kallikrein 3 and human kallikrein 2 are produced and secreted in the prostate and have important applications in the diagnosis of prostate cancer. Understanding the mechanism by which genetic variation in KLK3/Kallikrein 3 affects prostate cancer risk has important implications for study of the biological role of KLK3/Kallikrein 3 in prostate tumorigenesis.
References
Lundwall A.,et al.FEBS Lett. 214:317-322(1987).
Digby M.R.,et al.Nucleic Acids Res. 17:2137-2137(1989).
Klobeck H.-G.,et al.Nucleic Acids Res. 17:3981-3981(1989).
Lundwall A.,et al.Biochem. Biophys. Res. Commun. 161:1151-1159(1989).
Henttu P.,et al.Biochem. Biophys. Res. Commun. 160:903-910(1989).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.